갑상선 여포암과 휘틀세포암의 임상양상과 예후인자에 대한 비교 연구
Comparative Analysis About Clinical Manifestation and Prognostic Factors of Thyroid Follicular and Hurthle Cell Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives Follicular thyroid carcinoma (FTC) is the second commonthyroid cancer which comprises about 10% of differentiated thyroid carcinoma. Hurthle cellcarcinoma (HCC) is a relatively rare disease that has been classified as a subtype of FTC. However, there have been insufficient reports about these two similar thyroid cancers in SouthKorea due to low incidences. This study aims to present clinical features and evaluate prognosticfactors of FTC and HCC. Subjects and Method We reviewed data of 189 FTC and 12 HCC patients who underwentsurgery in our center from January 2000 to December 2020. Variables such as clinical characteristics,surgical method, pathologic result, post-operative treatment, survival rate and prognosticfactors were included in our study. Results As for age, 67.2% of patients in FTC group and 33.3% of patients in HCC groupwere older than 55 years-old (p=0.017). The average tumor sizes of FTC and HCC were 2.98and 3.1 cm, respectively. The 10-year overall survival rates of FTC and HCC were 96.5% and100%, respectively. The 10-year disease free survival rates of FTC and HCC were 89.1% and91.7%, respectively. Subclassification (widely invasive: p=0.036) and initial distant metastasis(p<0.001) were significant prognostic factors in FTC. Conclusion This study will be helpful for diagnosis and treatment of FTC and HCC, whichare relatively rare.
Abstract
Background and Objectives Follicular thyroid carcinoma (FTC) is the second commonthyroid cancer which comprises about 10% of differentiated thyroid carcinoma. Hurthle cellcarcinoma (HCC) is a relatively rare disease that has been classified as a subtype of FTC. However, there have been insufficient reports about these two similar thyroid cancers in SouthKorea due to low incidences. This study aims to present clinical features and evaluate prognosticfactors of FTC and HCC. Subjects and Method We reviewed data of 189 FTC and 12 HCC patients who underwentsurgery in our center from January 2000 to December 2020. Variables such as clinical characteristics,surgical method, pathologic result, post-operative treatment, survival rate and prognosticfactors were included in our study. Results As for age, 67.2% of patients in FTC group and 33.3% of patients in HCC groupwere older than 55 years-old (p=0.017). The average tumor sizes of FTC and HCC were 2.98and 3.1 cm, respectively. The 10-year overall survival rates of FTC and HCC were 96.5% and100%, respectively. The 10-year disease free survival rates of FTC and HCC were 89.1% and91.7%, respectively. Subclassification (widely invasive: p=0.036) and initial distant metastasis(p<0.001) were significant prognostic factors in FTC. Conclusion This study will be helpful for diagnosis and treatment of FTC and HCC, whichare relatively rare.
참고문헌 (26)
- Varadarajan VV, "Follicular thyroid carcinoma metastasis to the facial skeleton : A systematic review", BMC Cancer, 17(1), pp.225~ (2017)
- 모정아, "갑상선 여포암의 임상양상과 고찰", 대한이비인후-두경부외과학회지, 53(1), pp.30~36 (2010), 대한이비인후과학회
- Kakudo K, "The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives", Pathol Int, 68(12), pp.641~664 (2018)
- 김정준, "갑상선의 휘틀세포암 12예", 대한이비인후-두경부외과학회지, 63(12), pp.615~619 (2020), 대한이비인후과학회[DOI]
- Lopez-Penabad L, "Prognostic factors in patients with Hürthle cell neoplasms of the thyroid", Cancer, 97(5), pp.1186~1194 (2003)
- Mills SC, "Hürthle cell carcinoma of the thyroid : Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003", Eur J Surg Oncol, 35(3), pp.230~234 (2009)
- Sugino K, "Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?", Ann Surg Oncol, 20(9), pp.2944~2950 (2013)
- 이잔디, "갑상선 휘틀세포암(Hurthle Cell Carcinoma)의 임상적 특징 및 예후인자: 순수 소포상 갑상선암과의 비교", Annals of Surgical Treatment and Research, 74(2), pp.91~97 (2008), 대한외과학회
- Barnabei A, "Hurthle cell tumours of the thyroid. Personal experience and review of the literature", Acta Otorhinolaryngol Ital, 29(6), pp.305~311 (2009)
- Maizlin ZV, "Hurthle cell neoplasms of the thyroid : Sonographic appearance and histologic characteristics", J Ultrasound Med, 27(5), pp.751~757 (2008)
- Zhang JZ, "Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma", J Ultrasound Med, 33(2), pp.221~227 (2014)
- Cibas ES, "The 2017 Bethesda system for reporting thyroid cytopathology", Thyroid, 27(11), pp.1341~1346 (2017)
- Erickson LA, "Pathologic features, proliferative activity, and cyclin D1expression in Hurthle cell neoplasms of the thyroid", Mod Pathol, 13(2), pp.186~192 (2000)
- "Clinical practice guidelines in oncology-thyroid carcinoma. version 1. 2021" (2021)[URL]
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
- Ahmadi S, "Hürthle cell carcinoma : Current perspectives", Onco Targets Ther, 9, pp.6873~6884 (2016)
- Paramo JC, "Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid", Endocr Pract, 14(4), pp.447~451 (2008)
- Bhattacharyya N, "Survival and prognosis in Hürthle cell carcinoma of the thyroid gland", Arch Otolaryngol Head Neck Surg, 129(2), pp.207~210 (2003)
- Staubitz JI, "The surgical dilemma of primary surgery for follicular thyroid neoplasms", Best Pract Res Clin Endocrinol Metab, 33(4), pp.101292~ (2019)
- Goffredo P, "Hurthle cell carcinoma : A population-level analysis of 3311 patients", Cancer, 119(3), pp.504~511 (2013)
- Jillard CL, "Radioactive iodine treatment is associated with improved survival for patients with Hürthle cell carcinoma", Thyroid, 26(7), pp.959~964 (2016)
- McHenry CR, "Follicular adenoma and carcinoma of the thyroid gland", Oncologist, 16(5), pp.585~593 (2011)
- Chindris AM, "Clinical and molecular features of Hürthle cell carcinoma of the thyroid", J Clin Endocrinol Metab, 100(1), pp.55~62 (2015)
- Pryma DA, "Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients", J Nucl Med, 47(8), pp.1260~1266 (2006)
- Badulescu CI, "Follicular thyroid carcinoma-clinical and diagnostic findings in a 20-year follow up study", Acta Endocrinol(Buchar), 16(2), pp.170~177 (2020)
- Haigh PI, "The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart", Surgery, 138(6), pp.1152~1157 (2005)